US EditionPublished • loading... • Updated
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Oncolytics received FDA agreement on a Phase 3 trial design testing pelareorep with chemotherapy to improve survival in metastatic pancreatic cancer, a disease lacking immunotherapy options.
Summary by Madison Courier
3 Articles
3 Articles
Coverage Details
Total News Sources3
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
